Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy--China,2018-2019

作     者：Miaomiao Li Chang Song Aobo Dong Jing Hu Ruihua Kang Hui Xing Yuhua Ruan Yiming Shao Kunxue Hong Lingjie Liao 

作者机构：State Key Laboratory of Infectious Disease Prevention and ControlNational Center for AIDS/STD Control and PreventionChinese Center for Disease Control and PreventionBeijingChina 

出 版 物：《China CDC weekly》 (中国疾病预防控制中心周报（英文）)

年 卷 期：2022年第4卷第25期

页      面：535-540页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：Supported by the Ministry of Science and Technology of China(Grant number:2017ZX10201101002-004 2018ZX10721102-006) 

主　　题：Therapy Impact patients 

摘      要：Summary What is already known about this topic?While antiretroviral therapy(ART)has been rapidly scaled-up among the population living with human immunodeficiency virus or acquired immune deficiency syndrome(HIV/AIDS)patients since 2016,pretreatment drug resistance(PDR)has also increased.